Related Experiment Video
Updated: Apr 26, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.3K
Volume changes in remnant thyroid tissue after thyroidectomy in Graves disease
Pei-Yin Chen1, Cheng-Min Chao2, Ta-Jen Wu3
1National Cheng Kung University, College of Medicine and Hospital, Dou-Liou Branch, Yunlin, Taiwan, ROC.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|August 9, 2014
Summary
Younger age and smaller residual thyroid volume are key factors influencing thyroid gland size changes after surgery for Graves disease. These factors significantly impact remnant thyroid volume dynamics post-thyroidectomy.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Graves disease is a common cause of hyperthyroidism.
- Thyroidectomy is a surgical option for managing Graves disease.
- Post-thyroidectomy, residual thyroid tissue volume can change unpredictably.
Purpose of the Study:
- To identify factors influencing residual thyroid gland volume changes after thyroidectomy in patients with Graves disease.
- To elucidate predictors of thyroid remnant growth or shrinkage.
Main Methods:
- Ultrasonography was used to track thyroid volume changes in 101 Graves disease patients post-thyroidectomy (lobectomy and subtotal thyroidectomy).
- Patients were categorized based on residual thyroid size changes: increasing, stable, or shrinking.
- Evaluated factors included age, body weight, thyroid-stimulating hormone (TSH), TSH-receptor antibodies, anti-thyroid peroxidase (TPO) antibodies, pre- and post-operative thyroid volume, and lymphocyte infiltration.
Main Results:
- Younger age was identified as a significant factor in residual thyroid volume change.
- A lower residual volume ratio strongly correlated with changes in remnant thyroid size.
- No significant correlation was found between TSH levels, TSH-receptor antibody titers, and thyroid volume changes.
Conclusions:
- Age and residual volume ratio are the primary determinants of thyroid gland volume change after thyroidectomy in Graves disease patients.
- Understanding these factors can help predict post-surgical outcomes.
Related Concept Videos
Graves Disease II: Pathophysiology
15
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
15
Graves' Disease I: Introduction
15
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
15
Hyperthyroidism I: Introduction
23
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
23
Goiter
24
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
24
Hyperthyroidism II: Pathophysiology
18
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
18
The Thyroid Gland
6.9K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.9K

